Asia Pacific enteral nutrition market will grow by 9.7% annually with a total addressable market cap of $46.71 billion over 2020-2030 owing to rising number of patients suffering with chronic diseases and surge in adoption of enteral nutrition amid COVID-19 pandemic.
Highlighted with 34 tables and 55 figures, this 118-page report Asia Pacific Enteral Nutrition Market 2020-2030 by Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Asia Pacific enteral nutrition market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porters Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific enteral nutrition market in every aspect of the classification from perspectives of Nutrient, Application, Category, Product Form, End User, Distribution Channel, and Country.

Based on Nutrient, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Protein Based Nutrition
Standard Protein Diet
High Protein Supplement
Protein for Diabetic Patients
Other Protein-based Nutitions
Carbohydrates Based Nutrition
Fat Based Nutrition
Vitamin Based Nutrition
Other Nutrition Types

Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Critical Care
Diabetes
Neurology
Oncology
Other Applications

Based on Category, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Enteral Nutrition for Chronic Illness
Enteral Nutrition with Standard Formula

Based on Product Form, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Liquid Enteral Nutrition
Powder Enteral Nutrition

Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Pediatric
Adults
Geriatric

Based on Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Distribution by Hospitals
Distribution by Retail Pharmacies
Distribution by Online Pharmacies

Geographically, the following national/local markets are fully investigated:
Japan
China
South Korea
Australia
India
Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
For each country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Nutrient, Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific enteral nutrition market are assayed quantitatively and qualitatively through GMDs Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Abbott Laboratories
B. Braun Melsungen AG
Baxter International, Inc.
Danone S.A.
Fresenius Kabi AG
Asia Pacific Health Products, Inc.
Hormel Foods Corporation
Mead Johnson Nutrition Company
Meiji Holdings Co., Ltd.
Nestle S.A.
Reckitt Benckiser Group LLC
Victus, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)